在早期非小细胞肺癌中术后免疫疗法的挑战和争议:一个乐观的前景
1Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Republic of Korea.
Tuberculosis and respiratory diseases
|February 19, 2026
概括
周围手术免疫疗法可改善可切除非小细胞肺癌 (NSCLC) 的存活率. 这种策略结合了手术前和手术后的治疗方法,显示出一致的好处,特别是在晚期.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 胸部外科手术 胸部外科手术
背景情况:
- 免疫检查点抑制剂 (ICI) 已经彻底改变了非小细胞肺癌 (NSCLC) 治疗.
- 它们的应用已经从转移到可切除的疾病环境扩大.
- 新辅助和辅助免疫疗法证明了临床效用.
研究的目的:
- 审查术后免疫疗法在可切除的NSCLC中的理由,临床证据和安全性.
- 倡导采用术后免疫疗法作为标准的护理.
- 讨论新兴的生物标志物和基于ctDNA的监测,以改进治疗.
主要方法:
- 对第三期临床试验的审查 (例如,CheckMate 816,KEYNOTE-671,AEGEAN).
- 术后化疗免疫疗法的疗效和耐受性的分析.
- 检查患者选择标准和安全概况.
主要成果:
- 术后化学免疫疗法在现实实践中显示出有效性和耐受性.
- 这一策略显示出潜在的持续和持久的生存益处,特别是在IIIA阶段和高PD-L1NSCLC.
- 第三阶段试验证实了术后免疫治疗的可行性和积极结果.
结论:
- 周围手术免疫疗法代表了可切除NSCLC的战略进步.
- 有证据支持它越来越多地被采用为符合条件的患者的标准方法.
- 未来的方向包括生物标记驱动的精度和基于ctDNA的最小残留疾病监测.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
9.2K
06:03Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
16.7K
相关概念视频
02:49Cancer Therapies
8.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.2K
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
01:30Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K